Metformin treatment status and abdominal aortic aneurysm disease progression

Journal of Vascular Surgery

Volumn 64, Issue 1, 2016, Pages 46-54.e8

  Fujimura, Naoki ^a   Xiong, Jiang ^a   Kettler, Ellen B ^a   Xuan, Haojun ^a   Glover, Keith J ^a   Mell, Matthew W ^a   Xu, Baohui ^a   Dalman, Ronald L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD31 ANTIGEN; CD68 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELASTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MEGLITINIDE; METFORMIN; PRESCRIPTION DRUG; SULFONYLUREA; ANTIDIABETIC AGENT;

ABDOMINAL AORTA ANEURYSM; ADULT; AGE DISTRIBUTION; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; VERY ELDERLY; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; C57BL MOUSE; CALIFORNIA; DATA MINING; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC IMAGING; DISEASE MODEL; FACTUAL DATABASE; MIDDLE AGED; ODDS RATIO; ORAL DRUG ADMINISTRATION; PROTECTION; RETROSPECTIVE STUDY; STATISTICAL MODEL; TIME FACTOR;

ADMINISTRATION, ORAL; AGED; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; CALIFORNIA; DATA MINING; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; METFORMIN; MICE, INBRED C57BL; MIDDLE AGED; ODDS RATIO; PROTECTIVE FACTORS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84963864952     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2016.02.020     Document Type: Article

References (40)

1. P.W. Stather, D.A. Sidloff, I.A. Rhema, E. Choke, M.J. Bown, and R.D. Sayers A review of current reporting of abdominal aortic aneurysm mortality and prevalence in the literature Eur J Vasc Endovasc Surg 47 2014 240 242
2. F.A. Lederle, G.R. Johnson, S.E. Wilson, E.P. Chute, F.N. Littooy, D. Bandyk, and et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group Ann Intern Med 126 1997 441 449
3. F.A. Lederle The strange relationship between diabetes and abdominal aortic aneurysm Eur J Vasc Endovasc Surg 43 2012 254 256
4. P. De Rango, L. Farchioni, B. Fiorucci, and M. Lenti Diabetes and abdominal aortic aneurysms Eur J Vasc Endovasc Surg 47 2014 243 261
5. M.J. Sweeting, S.G. Thompson, L.C. Brown, and J.T. Powell Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms Br J Surg 99 2012 655 665
6. F. Zhang, K.C. Kent, D. Yamanouchi, Y. Zhang, K. Kato, S. Tsai, and et al. Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm Ann Surg 250 2009 416 423
7. J. Golledge, M. Karan, C.S. Moran, J. Muller, P. Clancy, A.E. Dear, and et al. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions Eur Heart J 29 2008 665 672
8. M.M. Dua, N. Miyama, J. Azuma, G.M. Schultz, M. Sho, J. Morser, and et al. Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease Surgery 148 2010 429 435
9. N. Miyama, M.M. Dua, J.J. Yeung, G.M. Schultz, T. Asagami, E. Sho, and et al. Hyperglycemia limits experimental aortic aneurysm progression J Vasc Surg 52 2010 975 983
10. E. Torsney, G. Pirianov, and G.W. Cockerill Diabetes as a negative risk factor for abdominal aortic aneurysm - does the disease aetiology or the treatment provide the mechanism of protection? Curr Vasc Pharmacol 11 2013 293 298
11. A. Thompson, J.A. Cooper, M. Fabricius, S.E. Humphries, H.A. Ashton, and H. Hafez An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance J Vasc Surg 52 2010 55 61.e2
12. H.J. Lowe, T.A. Ferris, P.M. Hernandez, and S.C. Weber STRIDE - an integrated standards-based translational research informatics platform AMIA Annu Symp Proc 2009 2009 391 395
13. K. Jung, P. LePendu, S. Iyer, A. Bauer-Mehren, B. Percha, and N.H. Shah Functional evaluation of out-of-the-box text-mining tools for data-mining tasks J Am Med Inform Assoc 22 2015 121 131
14. D.R. Morris, M.A. Cunningham, A.A. Ahimastos, B.A. Kingwell, E. Pappas, M. Bourke, and et al. TElmisartan in the management of abDominal aortic aneurYsm (TEDY): the study protocol for a randomized controlled trial Trials 16 2015 274
15. X.L. Wang, M.M. Thompson, W.P. Dole, R.L. Dalman, and A. Zalewski Standardization of outcome measures in clinical trials of pharmacological treatment for abdominal aortic aneurysm Expert Rev Cardiovasc Ther 10 2012 1251 1260
16. Y. Iida, B. Xu, H. Xuan, K.J. Glover, H. Tanaka, X. Hu, and et al. Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression Arterioscler Thromb Vasc Biol 33 2013 718 726
17. Y. Iida, B. Xu, G.M. Schultz, V. Chow, J.J. White, S. Sulaimon, and et al. Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms PLoS One 7 2012 e49642
18. M. Rouer, B.H. Xu, H.J. Xuan, H. Tanaka, N. Fujimura, K.J. Glover, and et al. Rapamycin limits the growth of established experimental abdominal aortic aneurysms Eur J Vasc Endovasc Surg 47 2014 493 500
19. K. Tajima, A. Nakamura, J. Shirakawa, Y. Togashi, K. Orime, K. Sato, and et al. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice Am J Physiol Endocrinol Metab 305 2013 E987 E998
20. G.B. West, and J.H. Brown The origin of allometric scaling laws in biology from genomes to ecosystems: towards a quantitative unifying theory of biological structure and organization J Exp Biol 208 Pt 9 2005 1575 1592
21. A.R. Brady, S.G. Thompson, F.G. Fowkes, R.M. Greenhalgh, and J.T. Powell Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance Circulation 110 2004 16 21
22. I. Pernicova, and M. Korbonits Metformin - mode of action and clinical implications for diabetes and cancer Nat Rev Endocrinol 10 2014 143 156
23. M.A. Pierotti, F. Berrino, M. Gariboldi, C. Melani, A. Mogavero, T. Negri, and et al. Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects Oncogene 32 2013 1475 1487
24. V.M. Victor, S. Rovira-Llopis, C. Banuls, N. Diaz-Morales, S. Lopez-Domenech, I. Escribano-Lopez, and et al. Metformin modulates human leukocyte/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients Atherosclerosis 242 2015 167 173
25. E. Giovannucci, D.M. Harlan, M.C. Archer, R.M. Bergenstal, S.M. Gapstur, L.A. Habel, and et al. Diabetes and cancer: a consensus report Diabetes Care 33 2010 1674 1685
26. M. Kinaan, H. Ding, and C.R. Triggle Metformin: an old drug for the treatment of diabetes but a new drug for the protection of the endothelium Med Princ Pract 24 2015 401 415
27. S.B. Vasamsetti, S. Karnewar, A.K. Kanugula, A.R. Thatipalli, J.M. Kumar, and S. Kotamraju Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis Diabetes 64 2015 2028 2041
28. P.W. Caton, N.K. Nayuni, J. Kieswich, N.Q. Khan, M.M. Yaqoob, and R. Corder Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5 J Endocrinol 205 2010 97 106
29. N. D'Onofrio, M. Vitiello, R. Casale, L. Servillo, A. Giovane, and M.L. Balestrieri Sirtuins in vascular diseases: emerging roles and therapeutic potential Biochim Biophys Acta 1852 2015 1311 1322
30. F. Marampon, G.L. Gravina, L. Scarsella, C. Festuccia, F. Lovat, C. Ciccarelli, and et al. Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis J Hypertens 31 2013 1972 1983
31. A. Csiszar, N. Labinskyy, A. Podlutsky, P.M. Kaminski, M.S. Wolin, C. Zhang, and et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations Am J Physiol Heart Circ Physiol 294 2008 H2721 H2735
32. C. Napoli, M.L. Balestrieri, V. Sica, L.O. Lerman, E. Crimi, G. De Rosa, and et al. Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis Heart Vessels 23 2008 124 133
33. J. Liu, X. Bi, T. Chen, Q. Zhang, S.X. Wang, J.J. Chiu, and et al. Shear stress regulates endothelial cell autophagy via redox regulation and Sirt1 expression Cell Death Dis 6 2015 e1827
34. P. De Rango, P. Cao, E. Cieri, G. Parlani, M. Lenti, G. Simonte, and et al. Effects of diabetes on small aortic aneurysms under surveillance according to a subgroup analysis from a randomized trial J Vasc Surg 56 2012 1555 1563
35. P.M. Thule, and G. Umpierrez Sulfonylureas: a new look at old therapy Curr Diab Rep 14 2014 473
36. E. van der Meij, G.G. Koning, P.W. Vriens, M.F. Peeters, C.A. Meijer, K.E. Kortekaas, and et al. A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation PLoS One 8 2013 e53882
37. H. Takagi, H. Yamamoto, K. Iwata, S. Goto, and T. Umemoto Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies Eur J Vasc Endovasc Surg 44 2012 287 292
38. C.P. Twine, and I.M. Williams Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms Br J Surg 98 2011 346 353
39. K.M. van de Luijtgaarden, F. Bastos Goncalves, S.E. Hoeks, T.M. Valentijn, R.J. Stolker, D. Majoor-Krakauer, and et al. Lower atherosclerotic burden in familial abdominal aortic aneurysm J Vasc Surg 59 2014 589 593
40. I. Mansi, C.R. Frei, C.P. Wang, and E.M. Mortensen Statins and new-onset diabetes mellitus and diabetic complications: a retrospective cohort study of US healthy adults J Gen Intern Med 30 2015 1599 1610